{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:57:05Z","timestamp":1773273425882,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:00:00Z","timestamp":1305158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:00:00Z","timestamp":1305158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/gt.2011.60","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T10:20:06Z","timestamp":1305195606000},"page":"25-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus"],"prefix":"10.1038","volume":"19","author":[{"given":"C-C","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-M","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-P","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-P","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-Y","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-S","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-P","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-J","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-C","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-h","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-H","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"BFgt201160_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM . Hepatitis B virus infection\u2014natural history and clinical consequences. N Engl J Med 2004; 350: 1118\u20131129.","journal-title":"N Engl J Med"},{"key":"BFgt201160_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cld.2004.12.009","volume":"9","author":"FX Bosch","year":"2005","unstructured":"Bosch FX, Ribes J, Cleries R, Diaz M . Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191\u2013211, v.","journal-title":"Clin Liver Dis"},{"key":"BFgt201160_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65\u201373.","journal-title":"JAMA"},{"key":"BFgt201160_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","volume":"130","author":"UH Iloeje","year":"2006","unstructured":"Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ . Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678\u2013686.","journal-title":"Gastroenterology"},{"key":"BFgt201160_CR5","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521\u20131531.","journal-title":"N Engl J Med"},{"key":"BFgt201160_CR6","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","volume":"131","author":"SJ Hadziyannis","year":"2006","unstructured":"Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 2006; 131: 1743\u20131751.","journal-title":"Gastroenterology"},{"key":"BFgt201160_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev.med.57.121304.131422","volume":"57","author":"ME Mailliard","year":"2006","unstructured":"Mailliard ME, Gollan JL . Emerging therapeutics for chronic hepatitis B. Annu Rev Med 2006; 57: 155\u2013166.","journal-title":"Annu Rev Med"},{"key":"BFgt201160_CR8","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/hep.1840380410","volume":"38","author":"M Konishi","year":"2003","unstructured":"Konishi M, Wu CH, Wu GY . Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 2003; 38: 842\u2013850.","journal-title":"Hepatology"},{"key":"BFgt201160_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.gastro.2004.12.007","volume":"128","author":"HL Wu","year":"2005","unstructured":"Wu HL, Huang LR, Huang CC, Lai HL, Liu CJ, Huang YT et al. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 2005; 128: 708\u2013716.","journal-title":"Gastroenterology"},{"key":"BFgt201160_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nbt824","volume":"21","author":"AP McCaffrey","year":"2003","unstructured":"McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003; 21: 639\u2013644.","journal-title":"Nat Biotechnol"},{"key":"BFgt201160_CR11","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nbt1122","volume":"23","author":"DV Morrissey","year":"2005","unstructured":"Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005; 23: 1002\u20131007.","journal-title":"Nat Biotechnol"},{"key":"BFgt201160_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1073\/pnas.0409028102","volume":"102","author":"SL Uprichard","year":"2005","unstructured":"Uprichard SL, Boyd B, Althage A, Chisari FV . Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA 2005; 102: 773\u2013778.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201160_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.gt.3302846","volume":"14","author":"CC Chen","year":"2007","unstructured":"Chen CC, Ko TM, Ma HI, Wu HL, Xiao X, Li J et al. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. Gene Therapy 2007; 14: 11\u201319.","journal-title":"Gene Therapy"},{"key":"BFgt201160_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/mt.2008.245","volume":"17","author":"CC Chen","year":"2009","unstructured":"Chen CC, Sun CP, Ma HI, Fang CC, Wu PY, Xiao X et al. Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. Mol Ther 2009; 17: 352\u2013359.","journal-title":"Mol Ther"},{"key":"BFgt201160_CR15","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","volume":"69","author":"LG Guidotti","year":"1995","unstructured":"Guidotti LG, Matzke B, Schaller H, Chisari FV . High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158\u20136169.","journal-title":"J Virol"},{"key":"BFgt201160_CR16","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1128\/JVI.80.6.2797-2807.2006","volume":"80","author":"P Meuleman","year":"2006","unstructured":"Meuleman P, Libbrecht L, Wieland S, De Vos R, Habib N, Kramvis A et al. Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus. J Virol 2006; 80: 2797\u20132807.","journal-title":"J Virol"},{"key":"BFgt201160_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1084\/jem.188.2.341","volume":"188","author":"Y Nakamoto","year":"1998","unstructured":"Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV . Immune pathogenesis of hepatocellular carcinoma. J Exp Med 1998; 188: 341\u2013350.","journal-title":"J Exp Med"},{"key":"BFgt201160_CR18","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.4049\/jimmunol.161.9.4520","volume":"161","author":"Y Shimizu","year":"1998","unstructured":"Shimizu Y, Guidotti LG, Fowler P, Chisari FV . Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 1998; 161: 4520\u20134529.","journal-title":"J Immunol"},{"key":"BFgt201160_CR19","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1128\/jvi.62.11.4144-4152.1988","volume":"62","author":"H Farza","year":"1988","unstructured":"Farza H, Hadchouel M, Scotto J, Tiollais P, Babinet C, Pourcel C . Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol 1988; 62: 4144\u20134152.","journal-title":"J Virol"},{"key":"BFgt201160_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1073\/pnas.86.1.207","volume":"86","author":"K Araki","year":"1989","unstructured":"Araki K, Miyazaki J, Hino O, Tomita N, Chisaka O, Matsubara K et al. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA 1989; 86: 207\u2013211.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201160_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1349-7006.1991.tb01834.x","volume":"82","author":"K Araki","year":"1991","unstructured":"Araki K, Nishimura S, Ochiya T, Okubo K, Miyazaki J, Matsubara K et al. Production and effect of infectious Dane particles in transgenic mice. Jpn J Cancer Res 1991; 82: 235\u2013239.","journal-title":"Jpn J Cancer Res"},{"key":"BFgt201160_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hep.21445","volume":"45","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Chen WL, Louie SG, Yen TS, Ou JH . Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice. Hepatology 2007; 45: 16\u201321.","journal-title":"Hepatology"},{"key":"BFgt201160_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1126\/science.284.5415.825","volume":"284","author":"LG Guidotti","year":"1999","unstructured":"Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV . Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825\u2013829.","journal-title":"Science"},{"key":"BFgt201160_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68\u201376.","journal-title":"J Virol"},{"key":"BFgt201160_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","volume":"13","author":"FV Chisari","year":"1995","unstructured":"Chisari FV, Ferrari C . Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29\u201360.","journal-title":"Annu Rev Immunol"},{"key":"BFgt201160_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.gastro.2008.10.048","volume":"136","author":"M Sugiyama","year":"2009","unstructured":"Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, Takahashi S et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology 2009; 136: 652\u2013662, e653.","journal-title":"Gastroenterology"},{"key":"BFgt201160_CR27","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1128\/jvi.76.5.2579-2584.2002","volume":"76","author":"Z Xu","year":"2002","unstructured":"Xu Z, Yen TS, Wu L, Madden CR, Tan W, Slagle BL et al. Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol 2002; 76: 2579\u20132584.","journal-title":"J Virol"},{"key":"BFgt201160_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000082090","volume":"48","author":"JS Koo","year":"2005","unstructured":"Koo JS, Seong JK, Park C, Yu DY, Oh BK, Oh SH et al. Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver. Intervirology 2005; 48: 16\u201322.","journal-title":"Intervirology"},{"key":"BFgt201160_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nbt.1526","volume":"27","author":"VW Keng","year":"2009","unstructured":"Keng VW, Villanueva A, Chiang DY, Dupuy AJ, Ryan BJ, Matise I et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 2009; 27: 264\u2013274.","journal-title":"Nat Biotechnol"},{"key":"BFgt201160_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cld.2007.08.005","volume":"11","author":"CJ Chen","year":"2007","unstructured":"Chen CJ, Iloeje UH, Yang HI . Long-term outcomes in hepatitis B: the REVEAL-HBV study. Clin Liver Dis 2007; 11: 797\u2013816, viii.","journal-title":"Clin Liver Dis"},{"key":"BFgt201160_CR31","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1128\/jvi.63.9.4069-4073.1989","volume":"63","author":"JA DeLoia","year":"1989","unstructured":"DeLoia JA, Burk RD, Gearhart JD . Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. J Virol 1989; 63: 4069\u20134073.","journal-title":"J Virol"},{"key":"BFgt201160_CR32","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.23163","volume":"50","author":"SH Wang","year":"2009","unstructured":"Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ . Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009; 50: 1392\u20131402.","journal-title":"Hepatology"},{"key":"BFgt201160_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","volume":"46","author":"SM Lin","year":"2007","unstructured":"Lin SM, Yu ML, Lee CM, Chien RN, Sheen IS, Chu CM et al. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma. J Hepatol 2007; 46: 45\u201352.","journal-title":"J Hepatol"},{"key":"BFgt201160_CR34","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/135965350701200816","volume":"12","author":"MF Yuen","year":"2007","unstructured":"Yuen MF, Seto WK, Chow DH, Tsui K, Wong DK, Ngai VW et al. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. Antivir Ther 2007; 12: 1295\u20131303.","journal-title":"Antivir Ther"},{"key":"BFgt201160_CR35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","volume":"59","author":"FV Chisari","year":"1989","unstructured":"Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 1145\u20131156.","journal-title":"Cell"},{"key":"BFgt201160_CR36","first-page":"3400","volume":"50","author":"HA Dunsford","year":"1990","unstructured":"Dunsford HA, Sell S, Chisari FV . Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res 1990; 50: 3400\u20133407.","journal-title":"Cancer Res"},{"key":"BFgt201160_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/351317a0","volume":"351","author":"CM Kim","year":"1991","unstructured":"Kim CM, Koike K, Saito I, Miyamura T, Jay G . HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 317\u2013320.","journal-title":"Nature"},{"key":"BFgt201160_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-8278(99)80172-X","volume":"31","author":"DY Yu","year":"1999","unstructured":"Yu DY, Moon HB, Son JK, Jeong S, Yu SL, Yoon H et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 1999; 31: 123\u2013132.","journal-title":"J Hepatol"},{"key":"BFgt201160_CR39","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/jvi.64.12.5939-5947.1990","volume":"64","author":"TH Lee","year":"1990","unstructured":"Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SL, Butel JS . Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 1990; 64: 5939\u20135947.","journal-title":"J Virol"},{"key":"BFgt201160_CR40","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1128\/JVI.79.3.1813-1823.2005","volume":"79","author":"YC Chou","year":"2005","unstructured":"Chou YC, Jeng KS, Chen ML, Liu HH, Liu TL, Chen YL et al. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. J Virol 2005; 79: 1813\u20131823.","journal-title":"J Virol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201160","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:49:41Z","timestamp":1686077381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["BFgt201160"],"URL":"https:\/\/doi.org\/10.1038\/gt.2011.60","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,12]]},"assertion":[{"value":"2 December 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}